RecruitingPhase 2NCT06629090
Brain Blood Vessel Responses to Changes in Blood Flow: Younger Cohort
Cerebrovascular Responses to Acute Hypoperfusion
Sponsor
University of Wisconsin, Madison
Enrollment
36 participants
Start Date
Dec 17, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Brain blood flow will be measured during a simulated postural change test and while breathing increased levels of carbon dioxide using magnetic resonance imaging.
Eligibility
Min Age: 20 YearsMax Age: 40 Years
Inclusion Criteria4
- Between the ages of 20-40 years
- Have a BMI ≤34.5 kg/m2
- are less than 72 in (182.88 cm) height
- Nonsmoker
Exclusion Criteria15
- Diagnosis of Mild Cognitive Impairment (MCI) or Alzheimer's disease (AD)
- History or evidence of hepatic disease, hematological disease, or peripheral vascular disease; severe kidney injury requiring hemodialysis
- History of cardiovascular disease including: severe congestive heart failure, coronary artery disease, ischemic heart disease (stents, coronary artery bypass grafts) and tachycardia
- Uncontrolled hypertension
- History of clinically significant ischemic or hemorrhagic stroke, or significant cerebrovascular disease
- Severe untreated obstructive sleep apnea
- History of diabetes with HbA1c greater than 9.5 percent
- Major neurologic disorders other than dementia (e.g., MS, ALS, brain surgery, etc.)
- Current or recent (less than1 year) major psychiatric condition (Axis I) or addictive disorders
- Significant surgical history
- Other significant medical conditions at investigators' discretion
- Contraindications to MRI
- Prescribed medications that interfere with prazosin
- Lactose allergy
- lower body will not fit in lower body negative pressure (LBNP) chamber (regardless of overall height and BMI)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEMRI
Participants will undergo an MRI scan while performing breathing and simulated postural change tasks.
DRUGPrazosin
A dose of prazosin will be administered based on body weight
DRUGPlacebo
Oral placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06629090
Related Trials
Study of New Magnetic Resonance Imaging Methods of the Brain
NCT000045771 location
Effect of Nutritional Ketosis on Alcohol Metabolism
NCT060656571 location
Quantitative T1rho Magnetic Resonance Imaging in Healthy Subjects
NCT049931961 location
Heart Transplantation - Renewal
NCT055213992 locations
MR Guidance for Liver and Pancreas
NCT035821891 location